These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6936869)

  • 21. Pediatric mycosis fungoides: a study of the human leukocyte antigen system among Israeli Jewish patients.
    Reiter O; Ben Amitai D; Amitay-Laish I; Israeli M; Pavlovsky L; Hodak E
    Arch Dermatol Res; 2017 Dec; 309(10):851-856. PubMed ID: 28948342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenetics of rheumatoid arthritis in Israel.
    Brautbar C; Naparstek Y; Yaron M; Amar A; Ehrenfeld M; Eliakim M; Bentwich Z; Cohen T; Korman SH; Albert ED
    Tissue Antigens; 1986 Jul; 28(1):8-14. PubMed ID: 3489300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial pemphigus vulgaris.
    Brenner S; Dorfman B; Himelfarb M
    Dermatologica; 1985; 171(1):38-40. PubMed ID: 3875508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Polymorphisms of HLA class II antigens in 33 Japanese pemphigus patients].
    Niizeki H
    Nihon Hifuka Gakkai Zasshi; 1991 Apr; 101(5):509-18. PubMed ID: 1679857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA and graft-versus-host disease: a population-based study of HLA phenotypes of Jewish and Arabic bone marrow transplanted patients in Israel.
    Bishara A; Brautbar C; Nagler A
    Leuk Res; 1997 Feb; 21(2):111-8. PubMed ID: 9112427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA class II allele associations in Korean patients with pemphigus.
    Lee CW; Yang HY; Kim SC; Jung JH; Hwang JJ
    Dermatology; 1998; 197(4):349-52. PubMed ID: 9873173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA class II antigens are associated with Japanese pemphigus patients.
    Niizeki H; Inoko H; Narimatsu H; Takata H; Sonoda A; Tadakuma T; Ando A; Tsuji K; Hashimoto T; Nishikawa T
    Hum Immunol; 1991 Aug; 31(4):246-50. PubMed ID: 1680837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews.
    Kwon OJ; Karni A; Israel S; Brautbar C; Amar A; Meiner Z; Abramsky O; Karussis D
    Arch Neurol; 1999 May; 56(5):555-60. PubMed ID: 10328250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-DR antigens in pemphigus among Japanese.
    Matsuyama M; Hashimoto K; Yamasaki Y; Shirakura R; Higuchi R; Miyajima T; Amemiya H
    Tissue Antigens; 1981 Feb; 17(2):238-9. PubMed ID: 7233418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complotypes in pemphigus vulgaris: differences between Jewish and non-Jewish patients.
    Ahmed AR; Yunis EJ; Alper CA
    Hum Immunol; 1990 Apr; 27(4):298-304. PubMed ID: 2318675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific immunoglobulin isotypes correlate with disease activity, morphology, duration and HLA association in Pemphigus vulgaris.
    Dhandha MM; Seiffert-Sinha K; Sinha AA
    Autoimmunity; 2012 Nov; 45(7):516-26. PubMed ID: 22779708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linkage of pemphigus vulgaris antibody to the major histocompatibility complex in healthy relatives of patients.
    Ahmed AR; Mohimen A; Yunis EJ; Mirza NM; Kumar V; Beutner EH; Alper CA
    J Exp Med; 1993 Feb; 177(2):419-24. PubMed ID: 8426112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NOD2/CARD15 genotype and phenotype differences between Ashkenazi and Sephardic Jews with Crohn's disease.
    Karban A; Waterman M; Panhuysen CI; Pollak RD; Nesher S; Datta L; Weiss B; Suissa A; Shamir R; Brant SR; Eliakim R
    Am J Gastroenterol; 2004 Jun; 99(6):1134-40. PubMed ID: 15180737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-DRB1*04 and DRB1*14 alleles are associated with susceptibility to pemphigus among Japanese.
    Miyagawa S; Higashimine I; Iida T; Yamashina Y; Fukumoto T; Shirai T
    J Invest Dermatol; 1997 Nov; 109(5):615-8. PubMed ID: 9347787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-E*0103X is associated with susceptibility to Pemphigus vulgaris.
    Bhanusali DG; Sachdev A; Rahmanian A; Gerlach JA; Tong JC; Seiffert-Sinha K; Sinha AA
    Exp Dermatol; 2013 Feb; 22(2):108-12. PubMed ID: 23362868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA B27 and ankylosing spondylitis in the Israeli population.
    Brautbar C; Porat S; Nelken D; Gabriel KR; Cohen T
    J Rheumatol Suppl; 1977; 3():24-32. PubMed ID: 266593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA polymorphism in Israel. 9. An overall comparative analysis.
    Bonné-Tamir B; Bodmer JG; Bodmer WF; Pickbourne P; Brautbar C; Gazit E; Nevo S; Zamir R
    Tissue Antigens; 1978 Mar; 11(3):235-50. PubMed ID: 653718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pemphigus Vulgaris and Pemphigus Foliaceus: Differences in Epidemiology and Mortality.
    Kridin K; Zelber-Sagi S; Bergman R
    Acta Derm Venereol; 2017 Oct; 97(9):1095-1099. PubMed ID: 28536732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-DR1 and rheumatoid arthritis in Israeli Jews: sequencing reveals that DRB1*0102 is the predominant HLA-DR1 subtype.
    de Vries N; Rønningen KS; Tilanus MG; Bouwens-Rombouts A; Segal R; Egeland T; Thorsby E; van de Putte LB; Brautbar C
    Tissue Antigens; 1993 Jan; 41(1):26-30. PubMed ID: 8456440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remarkable differences in the epidemiology of pemphigus among two ethnic populations in the same geographic region.
    Kridin K; Zelber-Sagi S; Khamaisi M; Cohen AD; Bergman R
    J Am Acad Dermatol; 2016 Nov; 75(5):925-930. PubMed ID: 27614531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.